DIVI'S LABORATORIES LTD.

NSE : DIVISLABBSE : 532488ISIN CODE : INE361B01024Industry : Pharmaceuticals & DrugsHouse : Divis Labs
BSE3450.9086.15 (+2.56 %)
PREV CLOSE ( ) 3364.75
OPEN PRICE ( ) 3366.00
BID PRICE (QTY) 3450.35 (5)
OFFER PRICE (QTY) 3453.40 (1)
VOLUME 64903
TODAY'S LOW / HIGH ( )3366.00 3463.80
52 WK LOW / HIGH ( )2776 4072.35
NSE3455.4587.6 (+2.6 %)
PREV CLOSE( ) 3367.85
OPEN PRICE ( ) 3367.05
BID PRICE (QTY) 3455.40 (67)
OFFER PRICE (QTY) 3457.00 (30)
VOLUME 835636
TODAY'S LOW / HIGH( ) 3367.05 3463.00
52 WK LOW / HIGH ( )2775 4074.4

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.